Briefs: Godavari Biorefineries and Anuh Pharma
Godavari Biorefineries receives patent from CNIPA
Godavari Biorefineries receives patent from CNIPA
The company’s largest center for medical device applications, serving the entire Asian market
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
The company showcased three core programs developed through this platform
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Changhua site meets international regulatory standards for global medical applications
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Subscribe To Our Newsletter & Stay Updated